BioSpace News Archive

Business

LivaNova Reports Third Quarter 2019 Results

LivaNova PLC, a market-leading medical technology and innovation company, reported results for the quarter ended September 30, 2019.

October 30, 2019
·
31 min read
Business

Lannett To Report Fiscal 2020 First-Quarter Financial Results, Host Conference Call On Wednesday, November 6

Lannett Company, Inc. announced that it will report financial results for its fiscal 2020 first quarter on Wednesday, November 6, 2019, after the market closes.

October 30, 2019
·
1 min read
Policy

Athenex Announces European Commission Grants Orphan Designations for Paclitaxel and Encequidar for the Treatment of Soft Tissue Sarcoma

Athenex, Inc. announced that it has received Orphan Designations from the European Commission for paclitaxel and encequidar for the treatment of soft tissue sarcoma, following a positive opinion from the European Medicines Agency

October 30, 2019
·
3 min read
Policy

Clearside Biomedical Announces Option Exercise by REGENXBIO for Global License for Use of SCS Microinjector™ in AAV Gene Therapy Delivery

Clearside Biomedical, Inc. announced that REGENXBIO Inc. has exercised its option under the previously announced option and license agreement to license Clearside’s proprietary, in-office SCS Microinjector™ for the delivery of adeno-associated virus -based therapeutics

October 30, 2019
·
4 min read
Business

IRADIMED CORPORATION Announces Third Quarter 2019 Financial Results

Reports third quarter 2019 revenue of $10.0 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.23

October 30, 2019
·
11 min read
Policy

Microbot Receives Notice of Allowance for U.S. Patent Covering its TipCAT™ Technology Platform - Oct. 30, 2019

In an expansion of its significant global patent estate, Microbot Medical Inc. announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for patent application No. 15/218,025, covering the Company’s TipCATTM technology platform.

October 30, 2019
·
4 min read
Business

Amicus Therapeutics to Announce Third Quarter 2019 Financial Results on November 11, 2019

Amicus Therapeutics announced that the Company will host a conference call and live audio webcast on Monday, November 11, 2019 at 8:30 a.m. ET to discuss financial results for the third quarter ended September 30, 2019.

October 30, 2019
·
1 min read
Deals

Emerald Health Therapeutics Announces Internal ReorganizationReorganization will cut costs and focus on improving cash flow and differentiated competitive positioning

Emerald Health Therapeutics, Inc. has announced an internal reorganization including the reduction of its workforce and other expenditures.

October 30, 2019
·
5 min read
Pharm Country

Dental Thought Leaders Share Their Thoughts on DMG’s New Crown Option

Both see revolutionary LuxaCrown “semi-permanent” material as here to stay

October 30, 2019
·
2 min read
Business

Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto-Immune Diseases

Seneca Biopharma, Inc. and Jiangsu QYuns Therapeutics Co., Ltd. jointly announce that they have entered into a non-binding term sheet for the licensing of certain assets owned by QYuns.

October 30, 2019
·
3 min read